Miami CTSI


Alessia Fornoni, M.D., Ph.D.

Dr. Alessia Fornoni Named Chief of Division of Nephrology and Hypertension


Alessia Fornoni, M.D., Ph.D., professor of medicine, and molecular and cellular pharmacology, Co-Director of Novel Methods for the Miami Clinical and Translational Science Institute, and Associate Director of the M.D./Ph.D. Program, has been named Chief of the Department of Medicine’s Division of Nephrology and Hypertension at the University of Miami Miller School of Medicine.

Annual Intensive Workshop Cultivates Careers in Translational Research


Clinicians interested in incorporating research into their clinical practice or want to explore clinical and translational research possibilities should attend the Miami CTSI's Foundations and Tools of Clinical and Translational Research Workshop on November 10-11, CRB room 1552.

Thinh H. Tran, M.D., M.B.A., signing Consent-to-Contact form, with patient access representative Miguel Martinez.

University of Miami Health System Patients Gain New Access to Clinical Studies


Patients at the University of Miami Health System are now being asked a new question when they check in for their appointment, one that will open a new opportunity to take advantage of the many innovative therapies and treatments available through the health system. In addition, patients will be asked if they would like to be contacted in the future about clinical studies for which they may qualify.

New Clinical Service to Provide UHealth Patients Access to Research Opportunities


Beginning in October, South Florida’s only academic medical system, UHealth — the University of Miami Health System, will take a major step in expanding the way its pioneering research touches the lives of patients. With the launch of the UHealth Consent-To-Contact Initiative, patients who come in for care will have a unique opportunity to take advantage of the many innovative therapies and treatments available through the health system.

Robert M. Califf, M.D.

FDA Commissioner Headlines Clinical Trials Symposium, September 14-15


Robert M. Califf, M.D., Commissioner of the U.S. Food and Drug Administration, will be the keynote speaker at a clinical trials symposium, “Improving Clinical Research in the Age of Precision Medicine,” September 14 and 15 from 8 a.m. to 5 p.m., at the University of Miami BankUnited Center on the Coral Gables campus. UM President Julio Frenk will deliver the welcome address.

Olveen Carrasquillo, M.D., and Erin Kobetz, Ph.D., M.P.H.

Innovative Community-Based Health Screening Initiative Prepared for Launch


Sylvester Comprehensive Cancer Center and other units of the University of Miami Miller School of Medicine are collaborating in the launch of an innovative health initiative to screen hard-to-reach populations in Miami-Dade County for multiple conditions and help them connect with appropriate care.

Apply For New Grant Writing Series Which Begins July 12


The Miami CTSI Grant Writing Workshop is back with a new series running July 12 to August 9. This highly interactive workshop is designed to provide step-by-step practical advice on writing the various sections of NIH R- or K-style grants.

From left, Azita Hamedani, M.D., M.P.H., Elaine Van der Put, Ph.D., M.S.P.H., Luanne E. Thorndyke, M.D., Ivette Motola, M.D., M.P.H., Julio Frenk, Lilian Abbo, M.D., Nanette Vega and Teri Bump.

Women in Academic Medicine Symposium Focuses on Creating Leadership Skills and Career Advancement


The Women and Minority Leadership and Professional Development Symposium — a first-of-its-kind interdisciplinary event sponsored by the Miller School of Medicine’s Women in Academic Medicine (WIAM) organization — attracted more than 300 professionals on May 13 for a day of medical-career-oriented advice and inspiration at the University of Miami’s Shalala Student Center.

Suhrud Rajguru, Ph.D

Translating Laboratory Discoveries into Better Hearing


By harnessing the various CTSA-supported resources available to investigators, Suhrud Rajguru, Ph.D., assistant professor in the Departments of Biomedical Engineering and Otolaryngology, has been able to advance his research on the neuroprotective effects of hypothermia during cochlear implant surgery.

From left, Jose Szapocznik, Ph.D., Thomas M. Hooton, M.D., Kenneth W. Goodman, Ph.D., Lillian Rivera, Ph.D., M.S.N., Administrator, Florida Department of Health, Miami-Dade County, John Beier, Sc.D., Micheline McCarthy, M.D., Ph.D., Esper G. Kallas, M.D., Ph.D., Mario Stevenson, Ph.D., Raymond F. Schinazi, Ph.D., Ronald Desrosiers, M.D., Ph.D., Christine L. Curry, M.D., Ph.D., Glen N. Barber, Ph.D., David I. Watkins, Ph.D., Rafael E. Campo, M.D., and Anna Marie Likos, M.D., M.P.H., Director, Division of Disease Control and Health Protection, Florida Department of Health.

Miller School Researchers Making Major Strides Against Zika Virus


Speaking at the Miller School’s “Zika Forum: State of the Science, Public Health Safety and Ethics,” Mario Stevenson, Ph.D., professor of medicine and Chief of Infectious Diseases, said, “We have a formidable team of virologists here who are up to the task of taking appropriate action against the virus.”

Register for Zika Forum: State of the Science, Public Health Safety and Ethics, March 23


The Miller School of Medicine, the Division of Infectious Diseases, the Department of Public Health Sciences and UHealth - the University of Miami Health System will present Zika Forum: State of the Science, Public Health Safety and Ethics, on Wednesday, March 23, from 1 to 5 p.m., at the Donna E. Shalala Student Center, 1330 Miller Drive, on the University of Miami Coral Gables campus.

From left, Mehrdad Nadji, M.D., David Watkins, Ph.D., Sylvia Daunert, Pharm.D., M.S., Ph.D., Glen N. Barber, Ph.D., Sapna Deo, Ph.D., Mario Stevenson, Ph.D., and Ronald Desrosiers, Ph.D.

Miami CTSI Supports Collaborative Research Team to Study Zika Virus


As the Zika virus outbreak develops as a public health emergency, both internationally and for South Florida, David Watkins, Ph.D., professor and Vice Chair of Research in the Department of Pathology, and a team of top Miller School researchers are rapidly working to develop better diagnostic tests and to understand the virus’s link to neurological complications such as microcephaly.

Joseph Panoff, M.D.

Study Shows Inferior Outcomes for African-American Pediatric Lymphoma Patients


Researchers from Sylvester Comprehensive Cancer Center have published a study showing that African-American pediatric Hodgkin lymphoma patients have inferior overall survival to their white and Hispanic peers. The findings, published in the journal Pediatric Blood & Cancer, are the largest study yet on racial and ethnic disparity in the pediatric Hodgkin lymphoma population.

Upcoming SBIR/STTR Workshops Can Steer You Toward Millions in Research and Development Funding


Each year, the federal Small Business Innovation Research and Small Business Technology Transfer programs award billions in non-dilutive grant funding to advance and commercialize game-changing technologies. On February 9 and 10, SBIR/STTR expert Lisa Kurek of BBC Entrepreneurial Training & Consulting will lead workshops focusing on program eligibility, selecting the right agency and key components of a competitive proposal.